Submit September:
Submit to JIT. Just do it.
Principal Investigators (PIs) are encouraged to upload materials to JIT areas incrementally, as soon as they are completed, to allow time for ORD staff to review and make decisions. There is no need to wait for all JIT areas to be ready as this causes additional delays.
Only Research and Development (R&D) office staff users with signing official (SO) roles can submit JIT data. After uploading documents into eRA Commons JIT, PIs should alert their local R&D office SO to submit the JIT data. Documents uploaded into JIT areas need to be submitted in order for Office of Research and Development (ORD) staff reviewing the documents to make their decision (approve, revise or disapprove) in a timely manner.
|
Webinar: A webinar on Pain/Opioid Use AMP RFAs will be held from 1 to 2 p.m. Eastern Time Tuesday, October 3, 2023
Link to register: https://veteransaffairs.webex.com/weblink/register/r1a221e63566ce266e0a48ad38f3bb099
New Focused RFA:
The Pain/Opioid Use Disorder Actively Managed Portfolio (POU-AMP) announces a funding opportunity for (BX/CX/HX/RX-24-037) Pharmacogenomics/Biomarker Studies to Guide Clinical Care in Pain and Opioid Use Disorder (OUD), which was released on September 22, 2023, and can be found at https://vaww.research.va.gov/funding/rfa.cfm.
This FOA/RFA accepts applications that involve:
- Use of machine learning and artificial intelligence algorithms to extract and code data from electronic health records and other sources to define specific clinical, genetic, and behavioral factors for use in predictive models to inform progression to or treatment for high impact chronic pain (HICP).
- Studies identifying behavioral, clinical, genetic, and epigenetic risk factors that can be used in predictive models to identify: 1) individuals with HICP; 2) individuals at risk of progressing to HICP; 3) individuals at risk of developing OUD as a result of prescribed opioids.
- Studies identifying behavioral, clinical, genetic, and epigenetic biomarkers that may predict responsiveness to specific pharmacologic or nonpharmacologic treatments for chronic painful conditions.
- Prospective studies validating behavioral, clinical, genetic or epigenetic biomarkers and models incorporating multiple variables to predict treatment approaches for individuals with HICP.
Note: Submitting investigators must adhere to all eligibility and preapplication requirements and submission deadlines detailed in the Pain/Opioid Use RFAs, found at: https://vaww.research.va.gov/funding/rfa.cfm
Scientific/Research Contacts for More Information:
Dr. Carol Fowler, BLRD, Carol.Fowler@va.gov
Dr. Jayanthi Sankar, CSRD, Jayanthi.Sankar@va.gov
Dr. Cathie Plouzek, HSRD, Cathie.Plouzek@va.gov
Dr. Audrey Kusiak, RRD, Audrey.Kusiak@va.gov
The CSRD Data Monitoring Committee (DMC), that provides data and safety monitoring for CSRD-funded projects, is seeking biostatisticians, neurologists, and other new members. For more information, please contact DMC Manager Dr. Tamara Paine.at Tamara.Paine@va.gov.
Career Development: VHACADEReview@va.gov
Clinical Trials: clin-review@va.gov
General Mailbox: VHABLRD-CSRD@va.gov (Please note this is a shared mailbox that should be used for general questions that will be triaged by staff to the appropriate individual.)
Just-in-Time Mailbox: VHACOBLCSRDJIT@va.gov
Scientific Portfolio/Program Managers: BLR&D and CSR&D Contact Information (va.gov)
Newsletter: Lucindia.Shouse@va.gov
|